Adult weight change and risk of postmenopausal breast cancer
- PMID: 16835425
- DOI: 10.1001/jama.296.2.193
Adult weight change and risk of postmenopausal breast cancer
Abstract
Context: Endogenous hormones are a primary cause of breast cancer. Adiposity affects circulating hormones, particularly in postmenopausal women, and may be a modifiable risk factor for breast cancer.
Objective: To assess the associations of adult weight change since age 18 years and since menopause with the risk of breast cancer among postmenopausal women.
Design, setting, and participants: Prospective cohort study within the Nurses' Health Study. A total of 87,143 postmenopausal women, aged 30 to 55 years and free of cancer, were followed up for up to 26 years (1976-2002) to assess weight change since age 18 years. Weight change since menopause was assessed among 49,514 women who were followed up for up to 24 years.
Main outcome measure: Incidence of invasive breast cancer.
Results: Overall, 4393 cases of invasive breast cancer were documented. Compared with those who maintained weight, women who gained 25.0 kg or more since age 18 years were at an increased risk of breast cancer (relative risk [RR], 1.45; 95% confidence interval [CI], 1.27-1.66; P<.001 for trend), with a stronger association among women who have never taken postmenopausal hormones (RR,1.98; 95% CI, 1.55-2.53). Compared with weight maintenance, women who gained 10.0 kg or more since menopause were at an increased risk of breast cancer (RR, 1.18; 95% CI, 1.03-1.35; P = .002 for trend). Women who had never used postmenopausal hormones, lost 10.0 kg or more since menopause, and kept the weight off were at a lower risk than those who maintained weight (RR, 0.43; 95% CI, 0.21-0.86; P = .01 for weight loss trend). Overall, 15.0% (95% CI, 12.8%-17.4%) of breast cancer cases in this population may be attributable to weight gain of 2.0 kg or more since age 18 years and 4.4% (95% CI, 3.6%-5.5%) attributable to weight gain of 2.0 kg or more since menopause. Among those who did not use postmenopausal hormones, the population attributable risks are 24.2% (95% CI, 19.8%-29.1%) for a weight gain since age 18 years and 7.6% (95% CI, 5.9%-9.7%) for weight gain since menopause.
Conclusions: These data suggest that weight gain during adult life, specifically since menopause, increases the risk of breast cancer among postmenopausal women, whereas weight loss after menopause is associated with a decreased risk of breast cancer. Thus, in addition to other known benefits of healthy weight, our results provide another reason for women approaching menopause to maintain or lose weight, as appropriate.
Similar articles
-
Dual effects of weight and weight gain on breast cancer risk.JAMA. 1997 Nov 5;278(17):1407-11. JAMA. 1997. PMID: 9355998
-
Adiposity, adult weight change, and postmenopausal breast cancer risk.Arch Intern Med. 2007 Oct 22;167(19):2091-102. doi: 10.1001/archinte.167.19.2091. Arch Intern Med. 2007. PMID: 17954804
-
Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study.Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):656-61. doi: 10.1158/1055-9965.EPI-04-0001. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767346
-
Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.J Natl Cancer Inst. 2015 Mar 10;107(2):djv088. doi: 10.1093/jnci/djv088. Print 2015 Feb. J Natl Cancer Inst. 2015. PMID: 25757865 Review.
-
Body weight: estimation of risk for breast and endometrial cancers.Am J Clin Nutr. 1996 Mar;63(3 Suppl):437S-41S. doi: 10.1093/ajcn/63.3.437. Am J Clin Nutr. 1996. PMID: 8615337 Review.
Cited by
-
The role of bariatric and metabolic surgery in the development, diagnosis, and treatment of endometrial cancer.Front Surg. 2022 Aug 31;9:943544. doi: 10.3389/fsurg.2022.943544. eCollection 2022. Front Surg. 2022. PMID: 36117808 Free PMC article. Review.
-
Metabolic pathways in obesity-related breast cancer.Nat Rev Endocrinol. 2021 Jun;17(6):350-363. doi: 10.1038/s41574-021-00487-0. Epub 2021 Apr 29. Nat Rev Endocrinol. 2021. PMID: 33927368 Free PMC article. Review.
-
Differential impact of body mass index and its change on the risk of breast cancer by molecular subtype: A case-control study in Japanese women.Springerplus. 2012 Dec;1(1):39. doi: 10.1186/2193-1801-1-39. Epub 2012 Oct 23. Springerplus. 2012. PMID: 23350064 Free PMC article.
-
Enhanced Susceptibility to Breast Cancer in Korean Women With Elevated Serum Gamma-Glutamyltransferase Levels: A Nationwide Population-Based Cohort Study.Front Oncol. 2021 May 27;11:668624. doi: 10.3389/fonc.2021.668624. eCollection 2021. Front Oncol. 2021. PMID: 34123839 Free PMC article.
-
PPARγ agonists target aromatase via both PGE2 and BRCA1.Cancer Prev Res (Phila). 2012 Oct;5(10):1169-72. doi: 10.1158/1940-6207.CAPR-12-0365. Cancer Prev Res (Phila). 2012. PMID: 23041473 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical